Skip to content

Lightwave Logic, Inc. LWLG Patent Costs Written Off

Patent Costs Written Off at other companies

Glaukos logo
GlaukosGKOS
$28.22M
Biogen logo
BiogenBIIB
$136.5M+22.1%
Universal Display logo
Universal DisplayOLED
$2.37M+24.3%
Illinois Tool Works logo
Illinois Tool WorksITW
$18M-14.3%
CarGurus, Inc. logo
CarGurus, Inc.CARG
$1.65M-13.2%
Ligand Pharmaceuticals logo
Ligand PharmaceuticalsLGND
$8.1M-1.9%

Other financials

Income statement

See full
Revenue$29.2K+27.3%
Gross profit$27.8K+33.2%
Operating income-$6.7M-37.1%
Net income-$6.3M-34.1%
EPS (diluted)-$0.040.0%

Balance sheet

See full
Cash & equivalents$75.1M+200%
Total debt$2.6M-6.4%
Total equity$81.3M+158%
Total assets$85.9M+141%

Cash flow

See full
Operating cash flow-$4.1M-16.4%
CapEx$450.5K-47.2%
Free cash flow-$4.5M-3.9%

Valuation

See full
Market cap$1.29B+747%
Enterprise value$1.22B+837%
P/S5,317.6×+3,586×

Profitability

See full
Gross margin97.5%+2.3pp
Operating margin-9,288.7%-3,592pp
Net margin-9,015.6%-3,489pp
FCF margin-6,272.6%-2,511pp

Returns & leverage

See full
Return on equity-38.8%-10.7pp
Debt / equity-0.1×
Current ratio34×+17.4×

Where this comes from

Reported directly by Lightwave Logic, Inc. in its filing.

Tagged under the XBRL concept lwlg:PatentCostsWrittenOff.

The official record: Lightwave Logic, Inc.’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →

Ask your AI about Lightwave Logic, Inc.'s patent costs written off.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Lightwave Logic, Inc.'s patent costs written off?
Lightwave Logic, Inc. (LWLG) reported patent costs written off of $130.5K in Q1 2026.
How has Lightwave Logic, Inc.'s patent costs written off changed year-over-year?
Lightwave Logic, Inc.'s patent costs written off increased by 22.7% year-over-year, from $106.33K to $130.5K.
What does patent costs written off mean?
The carrying value of patent-related intangible assets that are deemed impaired or no longer provide future economic benefit. This reflects the risk associated with the company's intellectual property portfolio and R&D investment success.